Phytoalexins in cancer prevention

Frontiers in Bioscience

Volumn 17, Issue 6, 2012, Pages 2035-2058

  Romagnolo, Donato F ^a   Davis, Cindy D ^b   Milner, John A ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer prevention; Cancer process; Nutrition; Phytoalexins; Plants; Review

Indexed keywords

ALLIUM SATIVUM; GLYCINE MAX; LYCOPERSICON ESCULENTUM; SOLANUM TUBEROSUM; VIGNA MUNGO; VIGNA UMBELLATA;

EID: 84860376752     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4036     Document Type: Review

References (199)

1. Stephen Boue, Thomas Cleveland, Carol Carter-Wientjes, Betty Shih, Deepak Bhatnagar, John McLachlan, and Matthew Burow: Phytoalexin-enriched functional foods. J Agric Food Chem 57, 2614-2622 (2009).
2. Hans VanEtten, John Mansfield, John Bailey, and Edward Farmer: Two Classes of Plant Antibiotics: Phytoalexins versus "Phytoanticipins" Plant Cell. 9, 1191- 1192 (1994).
3. Marina Naoumkina, Mohamed Farag, Lloyd Sumner, Yuhong Tang, Chang-Jun Liu, and Richard Dixon: Different mechanisms for phytoalexin induction by pathogen and wound signals in Medicago truncatula. Proc Natl Acad Sci USA 104, 17909-17915 (2007). (Pubitemid 350210866)
4. Roman Mezencev, Peter Kutschy, Aneta Salayova, Taylor Updegrove, and John McDonald: The design, synthesis and anticancer activity of new nitrogen mustard derivatives of natural indole phytoalexin 1- methoxyspirobrassinol. Neoplasma 56, 321-330 (2009).
5. Shozo Kobayashi, Chang-Kui Ding, Yasuhiro Nakamura, Ikuko Nakajima, and Ryoji Matsumoto: Kiwifruits (Actinidia deliciosa) transformed with a Vitis stilbene synthase gene produce piceid (resveratrolglucoside). Plant Cell Rep 19, 904-910 (2000).
6. Susanne Rühmann, Dieter Treutter, Steffi Fritsche, Karlis Briviba, and Iris Szankowski: Piceid (resveratrol glucoside) synthesis in stilbene synthase transgenic apple fruit. J Agric Food Chem 54, 4633-4640. (2006). (Pubitemid 44137190)
7. Giovanna Giovinazzo, Leone D'Amico, Annalisa Paradiso, Roberto Bollini, Francesca Sparvoli, and Laura DeGara: Antioxidant metabolite profiles in tomato fruit constitutively expressing the grapevine stilbene synthase gene. Plant Biotechnol J 31, 57-69 (2005). (Pubitemid 41556659)
8. John Hipskind and Nancy Paiva: Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Mol Plant Microbe Interact 13, 551-562 (2000). (Pubitemid 30221343)
9. Kevin Holland and Sean O'Keefe: Recent applications of peanut phytoalexins. Recent Pat Food Nutr Agric 2, 221- 232 (2010).
10. Bettina Deavours and Richard Dixon: Metabolic engineering of isoflavonoid biosynthesis in alfalfa. Plant Physiol 138, 2245-2259 (2005). (Pubitemid 43733566)
11. Soledade Pedras and Estifanos Yaya: Phytoalexins from Brassicaceae: news from the front. Phytochemistry 71, 1191-1197 (2010).
12. Mendel Friedman and Carol Levin: alpha-Tomatine content in tomato and tomato products determined by HPLC with pulsed amperometric detection. J Agric Food Chem 43, 1507-1511 (1995).
13. Jun Ning, Fanzuo Kong, Bangmao Lin, and Huide Lei: Large-scale preparation of the phytoalexin elicitor glucohexatose and its application as a green pesticide. J Agric Food Chem 51, 987-991 (2003).
14. Otto Daniel, Mattias Meier, Josef Schlatter, and Peter Frischknecht: Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides. Environ Health Perspect. 107, 109-14 (1999). (Pubitemid 29164205)
15. Soledade Pedras, Denis Okinyo-Owiti, Ken Thoms, and Adewale Adio: The biosynthetic pathway of crucifer phytoalexins and phytoanticipins: de novo incorporation of deuterated tryptophans and quasi-natural compounds. Phytochemistry 70, 1129-1138 (2009).
16. Farag Ibraheem, Iffa Gaffoor, and Surinder Chopra: Flavonoid phytoalexin-dependent resistance to anthracnose leaf blight requires a functional yellow seed1 in Sorghum bicolor. Genetics 70, 1129-1138 (2010).
17. Phillip Wharton and Ralph Nicholson: Temporal synthesis and radiolabelling of the sorghum 3- deoxyanthocyanidin phytoalexins and the anthocyanin, cyanidin 3-dimalonyl glucoside. New Phytologist 145, 457- 469 (2000). (Pubitemid 30165913)
18. Seun Yang, Seung-Hwan Paek, Nobuyuki Kozukue, Kap-Rang Lee, and Jung-Ae Kim: Alpha-chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1/2 phosphorylation. Food Chem Toxicol 44, 839-846 (2006).
19. Sinead Milner, Nigel Brunton, Peter Jones, Nora O'Brien, Stuart Collins, and Anita Maguire: Bioactivities of glycoalkaloids and their aglycones from solanum species. J Agric Food Chem 59, 3454-3484 (2011).
20. Kathryn Roupe, Connie Remsberg, Jamie Yáñez, and Neal Davies: Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1, 81-101 (2006).
21. Tao Shen, Xiao-Ning Wang, and Hong-Xiang Lou: Natural stilbenes: an overview. Nat Prod Rep. 26, 916-935. (2009).
22. Luigi Bavaresco: Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Exp Clin Res 29, 181-187 (2003). (Pubitemid 38568623)
23. Naznin Khatune, Ekramul Islam, Ekramul Haque, Proma Khondkar, and Mukhlesur Rahman: Antibacterial compounds from the seeds of Psoralea corylifolia. Fitoterapia 75, 228-230 (2004). (Pubitemid 38353091)
24. Kun Song and John Milner: The influence of heating on the anticancer properties of garlic. J Nutr 131, 1054S- 1057S (2001). (Pubitemid 32195006)
25. Tomonobu Toyomasu, Takuma Kagahara, Kazunori Okada, Jinichiro Koga, Morifumi Hasegawa, Wataru Mitsuhashi, Takeshi Sassa, and Hisakazu Yamane: Diterpene phytoalexins are biosynthesized in and exuded from the roots of rice seedlings. Biosci Biotechnol Biochem 72, 562-567 (2008). (Pubitemid 351355945)
26. Stephen Boue, Carol Carter, Kenneth Ehrlich, and Thomas Cleveland: Induction of the soybean phytoalexins coumestrol and glyceollin by Aspergillus. J Agric Food Chem 48, 2167-2172 (2000). (Pubitemid 30431206)
27. Luzia Modolo, Fernando Cunha, Marcia Braga, and Ione Salgado: Nitric oxide synthase-mediated phytoalexin accumulation in soybean cotyledons in response to the Diaporthe phaseolorum f. sp. meridionalis elicitor. Plant Physiol 130, 1288-1297 (2002). (Pubitemid 35352956)
28. Serena Landini, Madge Graham, and Terrence Graham: Lactofen induces isoflavone accumulation and glyceollin elicitation competency in soybean. Phytochemistry 62, 865- 874 (2003). (Pubitemid 36262390)
29. Stephen Boue, Matthew Burow, Thomas Wiese, Betty Shih, Steven Elliott, Carol Carter-Wientjes, John McLachlan, and Deepak Bhatnagar: Estrogenic and antiestrogenic activities of phytoalexins from red kidney bean (Phaseolus vulgaris L.). J Agric Food Chem 59, 112- 120 (2011).
30. Yan Yang, Ting Gong, Chao Liu, and Ruo-Yun Chen: Four new 2-arylbenzofuran derivatives from leaves of Morus alba L. Chem Pharm Bull 58, 257-260 (2010).
31. Zoi Papoutsi, Eva Kassi, Dimitra Papaevangeliou, Harris Pratsinis, Vassilis Zoumpourlis, Maria Halabalaki, Sofia Mitakou, Anastasios Kalofoutis, and Paraskevi Moutsatsou: Plant 2-arylobenzofurans demonstrate a selective estrogen receptor modulator profile. Steroids 69, 727-734 (2004). (Pubitemid 39576716)
32. David Schottenfeld and Jennifer Beebe-Dimmer: Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56, 69-83 (2006).
33. Sebastian Suerbaum and Pierre Michetti: Helicobacter pylori infection: N Engl J Med 347, 1175-1186 (2002).
34. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monogr Eval Carcinog Risks Hum. 61, 1-241 (1994).
35. James Scheiman and Alan Cutler: Helicobacter pylori and gastric cancer. Am J Med 106, 222-226 (1999). (Pubitemid 29115964)
36. Bettina Breuer-Katschinski, Kurt Nemes, Amy Marr, Bjorn Rump, Barbel Leiendecker, Norbert Breuer, and Harald Goebell: Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 60, 210-215 (1999). (Pubitemid 29221887)
37. Stefano Censini, Christina Lange, Zhaoying Xiang, Jean Crabtree, Paolo Ghiara, Mark Borodovsky, Rino Rappuoli, and Antonello Covacci: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93, 14648-14653 (1996).
38. Gail Mahady and Susan Pendland: Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroentero 95, 1849 (2000). (Pubitemid 30485041)
39. Yogeeshwer Shukla and Richa Singh: Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 1215, 1-8 (2011).
40. Gail Mahady, Susan Pendland, and Lucas Chadwick: Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. Am J Gastroenterol 98, 1440-1441 (2003). (Pubitemid 36741550)
41. Syed Zaidi, Kanwal Ahmed, Takeshi Yamamoto, Takashi Kondo, Khan Usmanghani, Makoto Kadowaki, and Toshiro Sugiyama: Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol Pharm Bull 32, 1931-1935 (2009).
42. Jean Crabtree, Antonello Covacci, Susan Farmery, Zhaoying Xiang, David Tompkins, Sarah Perry, Ivan Lindley, Rino Rappuoli: Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48, 41-45 (1995).
43. Paolo Ruggiero, Giacomo Rossi, Francesco Tombola, Laura Pancotto, Laura Lauretti, Giuseppe Del Giudice, and Mario Zoratti: Red wine and green tea reduce H pylori- or VacA-induced gastritis in a mouse model. World J Gastroenterol 13, 349-354 (2007). (Pubitemid 46178967)
44. Liam Murray, Athene Lane, Ian Harvey, Jenny Donovan, Prakash Nair, and Richard Harvey: Inverse relationship between alcohol consumption and active Helicobacter pylori infection: the Bristol Helicobacter project. Am J Gastroenterol 97, 2750-2755 (2002). (Pubitemid 35265424)
45. Steffen Rosenstock, Torben Jorgensen, Lief Andersen, and Olaf Bonnevie: Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 28, 32-40 (2000).
46. K.T. Augusti. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 34, 634-640 (1996). (Pubitemid 126496487)
47. Pablo Canizares, Ignacio Gracia, Luis Gómez, Carlos Martín de Argila, Daniel Boixeda, Antonio García, and Luis de Rafael: Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog 20, 397-401 (2004). (Pubitemid 38204214)
48. Jinkun Shen, Larry Davis, Judy Wallace, Yen Cai, and Larry Lawson: Enhanced diallyl trisulfide has in vitro synergy with amphotericin B against Cryptococcus neoformans. Planta Med 62, 415-418. (1996). (Pubitemid 26370332)
49. Shuang Liu, Yundong Sun, Wenjuan Li, Han Yu, Xi Li, Zhifang Liu, Jiping Zeng, Yabin Zhou, Chunyan Chen, and Jihui Jia: The antibacterial mode of action of allitridi for its potential use as a therapeutic agent against Helicobacter pylori infection. FEMS Microbiol Lett 303, 183-189 (2010).
50. Masaki Iimuro, Hideyuki Shibata, Toshihiko Kawamori, Takayuki Matsumoto, Tetsuo Arakawa, Takashi Sugimura, and Keiji Wakabayashi: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187, 61-68 (2002). (Pubitemid 35279333)
51. Mitchell Gail and Wei-ChengYou: A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. J Nutr 136, 813S-815S (2006). (Pubitemid 43363783)
52. Johan Billing and Paul Sherman: Antimicrobial functions of spices: why some like it hot. Q Rev Biol 73, 3- 49 (1998).
53. Rajendra Mehta, Jinfang Liu, Andreas Constantinou, Cathy Thomas, Michael Hawthorne, Min You, Clarissa Gerhaüser, John Pezzuto, Richard Moon, and Robert Moriarty: Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 16, 399-404 (1995).
54. Rajendra Mehta, Jinfang Liu, Andreas Constantinou, Michael Hawthorne, John Pezzuto, Richard Moon, and Robert Moriarty: Structure-activity relationships of brassinin in preventing the development of carcinogeninduced mammary lesions in organ culture. Anticancer Res 14, 1209-1213 (1994). (Pubitemid 24272592)
55. Clarissa Gerhäuser, Min You, Jinfang Liu, Robert Moriarty, Michael Hawthorne, Rajendra Mehta, Richard Moon, and John Pezzuto: Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57, 272-278. (1997). (Pubitemid 27036605)
56. Martina Pilátová, Marek Sarisský, Peter Kutschy, Andrej Mirossay, Roman Mezencev, Zalmira Curillová, Miro Suchý, Kazuaki Monde, Ladislav Mirossay, and Jan Mojzis: Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells. Leuk Res 29, 415-421 (2005). (Pubitemid 40255816)
57. Peter Kutschy, Aneta Salayová, Zalmira Curillová, Tibor Kozár, Roman Mezencev, Jan Mojzis, Martina Pilátová, Eva Balentová, Pavel Pazdera, Marian Sabol, and Michaela Zburová: 2- (substituted phenyl)amino analogs of 1-methoxyspirobrassinol methyl ether: synthesis and anticancer activity. Bioorg Med Chem 17, 3698-3712 (2009).
58. Peter Csomós, Istvan Zupkó, Borbala Réthy, Lajos Fodor, George Falkay, and Gabor Bernáth: Isobrassinin and its analogues: novel types of antiproliferative agents. Bioorg Med Chem Lett 16, 6273-6276 (2006). (Pubitemid 44709904)
59. Tinku Banerjee, James Duhadaway, Paul Gaspari, Erika Sutanto-Ward, David Munn, Andrew Mellor, William Malachowski, George Prendergast, and Alexander Muller: A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2, 3- dioxygenase. Oncogene 27, 2851-2857 (2008). (Pubitemid 351620442)
60. Chun-Hat Shih, Siu-On Siu, Ricky Ng, Elaine Wong, Lawrence Chiu, Ivan Chu, and Clive Lo: Quantitative analysis of anticancer 3-deoxyanthocyanidins in infected sorghum seedlings. J Agric Food Chem 55, 254-259 (2007). (Pubitemid 46586303)
61. Kap-Rang Lee, Nobuyuki Kozukue, Jae-Sook Han, Joon-Hong Park, Eun-Young Chang, Eun-Jung Baek, Jong-Sun Chang, and Mendel Friedman: Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem 52, 2832-2839 (2004).
62. Mendel Friedman, Kap-Rang Lee, Hyun-Jeong Kim, In-Seon Lee, and Nobuyuke Kozukue: Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. J Agric Food Chem 53, 6162-6169 (2005). (Pubitemid 41126663)
63. Sau Lee, Wei Zhang, and Barbara Sanderson: Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem 56, 7572-7577 (2008).
64. Po-Lin Kuo, Lien-Chai Chiang, and Chun-Ching Lin: Resveratrol- induced apoptosis is mediated by p53- dependent pathway in Hep G2 cells. Life Sci 72, 23-34 (2002). (Pubitemid 35291091)
65. Gregory Gatouillat, Emilie Balasse, Debora Joseph-Pietras, Hamid Morjani, and Claudie Madoulet: Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J Cell Biochem 110, 893- 902 (2010).
66. Dixan Benitez, Eulalia Pozo-Guisado, Alberto Alvarez-Barrientos, Pedro Fernandez-Salguero, and Enrique Castellón: Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28, 282-293 (2007). (Pubitemid 46423911)
67. Nihal Ahmad, Vaqar Adhami, Farrukh Afaq, Denise Feyes, and Hasan Mukhtar: Resveratrol causes WAF- 1/p21-mediated G (1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7, 1466-1473 (2001). (Pubitemid 32708704)
68. Arianna Kim, Yucui Zhu, Huijie Zhu, Lydia Han, Levy Kopelovich, David Bickers, and Mohammed Athar: Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol 15, 538-546 (2006). (Pubitemid 43834489)
69. Zeev Estrov, Shishir Shishodia, Stefan Faderl, David Harris, Quin Van, Hagop Kantarjian, Moshe Talpaz, and Bharat Aggarwal: Resveratrol blocks interleukin-1betainduced activation of the nuclear transcription factor NFkappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102, 987-995 (2003). (Pubitemid 36917794)
70. Andrew Joe, Hui Liu, Masumi Suzui, Muhammet Vural, Danhua Xiao, and Bernard Weinstein: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8, 893-903 (2002). (Pubitemid 34742123)
71. Freja Wolter, Bora Akoglu, Antje Clausnitzer, and Jurgen Stein: Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131, 2197-2203 (2001). (Pubitemid 32720652)
72. Yun Chen, Sheng-Hong Tseng, Hong-Shiee Lai, and Wei-Jao Chen: Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136, 57-66 (2004). (Pubitemid 38834220)
73. Takayuki Shimizu, Tomonori Nakazato, Ming Xian, Morihiko Sagawa, Yasuo Ikeda, and Mahasiro Kizaki: Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol 71, 742-750 (2006). (Pubitemid 43208830)
74. Alpna Tyagi, Rana Singh, Chapla Agarwal, Sunitha Siriwardana, Robert Sclafani, and Rajesh Agarwal: Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26, 1978-1987 (2005). (Pubitemid 41631273)
75. Susanne Gatz and Lisa Wiesmüller: Take a break- resveratrol in action on DNA. Carcinogenesis 29, 321-332 (2008). (Pubitemid 351359671)
76. Xin He, Yu Wang, Jinbong Zhu, Mohammed Orloff, and Charis Eng: Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett 301, 168-176 (2011).
77. Yu-Chin Liang, Shu-Huei Tsai, Linda Chen, Shoei-Yn Lin-Shiau, and Lin Jen-Kun: Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol 65, 1053-1060 (2003). (Pubitemid 36349745)
78. Agnes Rimando, Muriel Cuendet, Cristian Desmarchelier, Rajendra Mehta, John Pezzuto, and Stephen Duke: Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 550, 3453-3457 (2002). (Pubitemid 34580577)
79. Agnes Rimando, John Pezzuto, Norman Farnsworth, Thawatchai Santisuk, and Vichai Reutrakul: Revision of the NMR assignments of pterostilbene and dihydrodehydro-diconiferyl alcohol: cytotoxic constituents from Anogeissus acuminate. Nat Prod Lett 4, 267-272 (1994). (Pubitemid 24254356)
80. Patrick Mannal, Julie Alosi, John Schneider, Debbie McDonald, and David McFadden: Pterostilbene inhibits pancreatic cancer in vitro. J Gastrointest Surg 14, 873-879 (2010).
81. Rong-Jane Chen, Chi-Tang Ho, and Ying-Jan Wang: Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol Nutr Food Res 54, 1819-1832 (2010).
82. Nanjoo Suh, Shiby Paul, Xingpei Hao, Barbara Simi, Hang Xiao, Agnes Rimando, and Bandaru Reddy: Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin Cancer Res 13, 350-355 (2007). (Pubitemid 46121889)
83. Shiby Paul, Andrew DeCastro, Hong Lee, Amanda Smolarek, Jae So, Barbara Simi, Chung Wang, Renping Zhou, Agnes Rimando, and Nanjoo Suh: Dietary intake of pterostilbene, a constituent of blueberries, inhibits the betacatenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis 31, 1272-1278 (2010).
84. Yi-Siou Chiou, Mei-Ling Tsai, Ying-Jan Wang, An-Chin Cheng, Wei-Ming Lai, Vladimir Badmaev, Chi-Tang Ho, and Min-Hsiung Pan: Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice. J Agric Food Chem 58, 8833-8841 (2010).
85. Yi-Siou Chiou, Mei-Ling Tsai, Kalyanam Nagabhushanam, Ying-Jan Wang, Chih-Hsiung Wu, Chi-Tang Ho, and Min-Hsiung Pan: Pterostilbene Is More Potent than Resveratrol in Preventing Azoxymethane (AOM)-Induced Colon Tumorigenesis via Activation of the NF-E2-Related Factor 2 (Nrf2)-Mediated Antioxidant Signaling Pathway. J Agric Food Chem 59, 2725-2733 (2011).
86. Min-Hsiung Pan, Yen-Hui Chang, Mei-Ling Tsai, Ching-Shu Lai, Sheng-Yow Ho, Vladimir Badmaev, and Chi-Tang Ho: Pterostilbene suppressed lipopolysaccharide-induced upexpression of iNOS and COX-2 in murine macrophages. J Agric Food Chem 56, 7502-7509 (2008).
87. Shiby Paul, Agnes Rimando, Hong Lee, Yan Ji, Bandaru Reddy, and Nanjoo Suh: Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. Cancer Prev Res 2, 650-657 (2009).
88. Wen-Fei Chiou, Ming-Jaw Don, Jyh-Fei Liao, and Bai-Lu Wei: Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways. Eur J Pharmacol 650, 102-109 (2011).
89. Raj Kumar, Sowmyalakshmi Srinivasan, Srinivas Koduru, Pallab Pahari, Jurgen Rohr, Natasha Kyprianou, and Chendil Damodaran: Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells. Cancer Prev Res 2, 234-243 (2009).
90. Raj Kumar, Sowmyalakshmi Srinivasan, Pallab Pahari, Jurgen Rohr, and Chendil Damodaran: Activating stressactivated protein kinase-mediated cell death and inhibiting epidermal growth factor receptor signaling: a promising therapeutic strategy for prostate cancer. Mol Cancer Ther 9, 2488-2496 (2010).
91. Keren Hirsch, Michael Danilenko, Judith Giat, Talia Miron, Aharon Rabinkov, Meir Wilchek, David Mirelman, Joseph Levy, and Yoav Sharoni: Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 38, 245-254 (2000). (Pubitemid 32762025)
92. Dominique Delmas, Eric Solary, and Norbert Latruffe: Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18, 1100-1121 (2011).
93. Chibuike Udenigwe, Vanu Ramprasath, Rotimi Aluko, and Peter Jones: Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 66, 445-454 (2008).
94. Sandra Ulrich, Freya Wolter, and Jurgen Stein: Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 49, 452-461 (2005). (Pubitemid 40780392)
95. Jairam Vanamala, Lavanya Reddivari, Sridhar Radhakrishnan, and Sridhar Tarver: Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10, 238 (2010).
96. Adhip Majumdar, Sanjeev Banerjee, Jyoti Nautiyal, Bhaumik Patel, Vaishali Patel, Jianhua Du, Yingjie Yu, Althea Elliott, Althea Levi, and Fazlul Sarkar: Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer 61, 544-553 (2009).
97. Hung-Yun Lin, Mingzeng Sun, Heng-Yuan Tang, Tessa Simone, Yun-Hsuan Wu, Jennifer Grandis, James Cao, Paul Davis, and Faith Davis: Resveratrol causes COX- 2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J Cell Biochem 104, 2131-2142 (2008).
98. Moussa Alkhalaf: Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells. Pharmacology 80, 134-143 (2007). (Pubitemid 47230707)
99. Neetu Singh, Manisha Nigam, Vishal Ranjan, Ramesh Sharma, Anil Balapure, and Srikanta Rath: Caspase mediated enhanced apoptotic action of cyclophosphamide and resveratrol-treated MCF-7 cells. J Pharmacol Sci 109, 473-485 (2009).
100. Aristotle Liontas and Herman Yeger: Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24, 987-998 (2004). (Pubitemid 38625049)
101. Min Kim, Laura Trudel, and Gerald Wogan: Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res 29, 3733-3740 (2009).
102. Qinghe Chen, Suthakar Ganapathy, Karan Singh, Sharmila Shankar, and Rakesh Srivastava: Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5, e15288 (2010).
103. Maaike Van den Berg and Boudewijn Burgering: Integrating opposing signals toward Forkhead box O. Antioxid Redox Signal 14, 607-621 (2011).
104. Jen-Liang Su, Ming-Tsan Lin, Chih-Chen Hong, Cheng-Chi Chang, Shine-Gwo Shiah, Cheng-Wen Wu, Szu-Ta Chen, Yat-Pang Chau, and Min-Liang Kuo: Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 26, 1-10 (2005). (Pubitemid 40207693)
105. Jin-Taek Hwang, Dong Kwak, Sun Lin, Hye Kim, Young Kim, and Ock Park: Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci 1095, 441-448 (2007). (Pubitemid 47092474)
106. Sarah Fogarty and Grahame Hardie: Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804, 581-591 (2010).
107. Reuben Shaw: LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol 196, 65-80 (2009).
108. Suthakar Ganapathy, Qinghe Chen, Karan Singh, Sharmila Shankar, and Rakesh Srivastava: Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One 5, e15627 (2010).
109. Christian Billard, Jean-Claude Izard, Viviana Roman, Catherine Kern, Claire Mathiot, Franck Mentz, and Jean- Pierre Kolb: Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk Lymphoma 43, 1991-2002 (2002).
110. John Schneider, Julie Alosi, Debbie McDonald, and David McFadden: Effects of pterostilbene on melanoma alone and in synergy with inositol hexaphosphate. Am J Surg 198, 679-684 (2009).
111. John Schneider, Julie Alosi, Debbie McDonald, and David McFadden: Pterostilbene inhibits lung cancer through induction of apoptosis. J Surg Res 161, 18-22 (2010).
112. Julie Alosi, Debbie McDonald, John Schneider, Alicia Privette, and David McFadden: Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res 161, 195-201 (2010).
113. Min-Hsiung Pan, Yen-Hui Chang, Vladimir Badmaev, Kalyanam Nagabhushanam, and Chi-Tang Ho: Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J Agric Food Chem 55, 7777-7785 (2007). (Pubitemid 47522187)
114. Zhiqiang Pan, Ameeta Agarwal, Tao Xu, Qin Feng, Scott Baerson, Stephen Duke, and Agnes Rimando: Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med Genomics 1, 7 (2008).
115. Woongchon Mar, Kang-Hoon Je, and Eun-Kyoung Seo: Cytotoxic constituents of Psoralea corylifolia. Arch Pharm Res 24, 211-213 (2001).
116. Yong-Man Yang, Jin-Won Hyun, Min-Sook Sung, Ha-Sook Chung, Byong-Kak Kim, Woo-Hyun Paik, Sam-Sik Kang, and Jae-Gahb Park: The cytotoxicity of psoralidin from Psoralea corylifolia. Planta Med 62, 353- 354 (1996). (Pubitemid 26272515)
117. Sowmyalakshmi Srinivasan, Raj Kumar, Srinivas Koduru, Aaditya Chandramouli, and Chendil Damodaran: Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer. Apoptosis 15, 153-161 (2010).
118. Hisashi Matsuda, Sachie Kiyohara, Sachiko Sugimoto, Shin Ando, Seikou Nakamura, and Masayuki Yoshikawa: Bioactive constituents from Chinese natural medicines. XXXIII. Inhibitors from the seeds of Psoralea corylifolia on production of nitric oxide in lipopolysaccharideactivated macrophages. Biol Pharm Bull 32, 147-149 (2009).
119. Eun-Kyung Kim, Kang-Beom Kwon, Byung-Cheul Shin, Eun-A Seo, Young-Rae Lee, Jong-Suk Kim, Jin-Woo Park, Byung-Hyun Park, and Do-Gon Ryu: Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor kappaB and caspase-3. Life Sci 77, 824-836 (2005). (Pubitemid 40780006)
120. Olen Domon, Lynda McGarrity, Michelle Bishop, Makoto Yoshioka, James Chen, and Suzanne Morris: Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK (+/-) human lymphoblastoid cells. Mutat Res 474, 129-137 (2001). (Pubitemid 32184762)
121. Lavanya Reddivari, Jairam Vanamala, Stephen Safe, and Creighton Miller: The bioactive compounds alphachaconine and gallic acid in potato extracts decrease survival and induce apoptosis in LNCaP and PC3 prostate cancer cells. Nutr Cancer 62, 601-610 (2010).
122. Lavanya Reddivari, Jairam Vanamala, Sudhakar Chintharlapalli, Stephen Safe, and Creighton Miller: Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspasedependent and caspase-independent pathways. Carcinogenesis 28, 2227-2235 (2007). (Pubitemid 47543385)
123. Wenlu Zhang, Minwen Ha, Yuehua Gong, Ying Xu, Nannan Dong, and Yuan Yuan: Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways. Oncol Rep 24, 1585-1592 (2010).
124. Suby Oommen, Ruby Anto, Gopal Srinivas, and Gopal Karunagaran: Allicin (from garlic) induces caspasemediated apoptosis in cancer cells. Eur J Pharmacol 485, 97-103 (2004). (Pubitemid 38134402)
125. Wolf Bat-Chen, Tal Golan, Irena Peri, Zvi Ludmer, and Betty Schwartz: Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr Cancer 62, 947-957 (2010).
126. Talia Miron, Meir Wilchek, Ayala Sharp, Yoshihito Nakagawa, Makoto Naoi, Yoshinori Nozawa, and Yukihiro Akao: Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in HL60 and U937 cells. J Nutr Biochem 19, 524-535 (2008).
127. Fabian Arditti, Aharon Rabinkov, Talia Miron, Yair Reisner, Alain Berrebi, Meir Wilchek, and David Mirelman: Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol Cancer Ther 4, 325-331 (2005). (Pubitemid 40340211)
128. Youn-Hee Joung, Eun-Joung Lim, Mi-Sun Kim, So Lim, So-Young Yoon, Young Lim, Young Yoo, Sang-Kyu Ye, Taekyu Park, Ill-Min Chung, Ki-Yeol Bae, and Young Mok Yang: Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Int J Oncol 33, 477-484 (2008).
129. Seung Lee, Ill-Min Chung, Yeong Jin, Yeon Song, Su Seo, Bong Park, Kwang Cho, Ki Yoo, Tae-Hyun Kim, Su-Bog Yee, Yoe-Sik Bae, and Young Yoo: Momilactone B, an allelochemical of rice hulls, induces apoptosis on human lymphoma cells (Jurkat) in a micromolar concentration. Nutr Cancer 60, 542-551 (2008). (Pubitemid 351918546)
130. Sun-Jung Kim, Hae-Ryong Park, Eunju Park, and Seung-Cheol Lee: Cytotoxic and antitumor activity of momilactone B from rice hulls. J Agric Food Chem 55, 1702-1706 (2007). (Pubitemid 46479572)
131. Mathias Leber and Thomas Efferth: Molecular principles of cancer invasion and metastasis (review). Int J Oncol 34, 881-895 (2009).
132. Ming-Kun Lu, Yuan-Wei Shih, Tzu-Tsung Chang Chien, Li-Heng Fang, Hsiang-Ching Huang, and Pin-Shern Chen: α-Solanine inhibits human melanoma cell migration and invasion by reducing matrix metalloproteinase-2/9 activities. Biol Pharm Bull 33, 1685-1691 (2010).
133. Yuan-Wei Shih, Pin-Shern Chen, Cheng-Hsun Wu, Ya-Fang Jeng, and Chau-Jong Wang: Alpha-chaconinereduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells. J Agric Food Chem 55, 11035-11043 (2007).
134. Ming-Kun Lu, Pei-Hsieng Chen, Yuan-Wei Shih, Ya-Ting Chang, En-Tze Huang, Cheng-Ruei Liu, and Pin-Shern Chen: alpha-Chaconine inhibits angiogenesis in vitro by reducing matrix metalloproteinase-2. Biol Pharm Bull 33, 622-630 (2010).
135. Eun-Wha Son, Sung-Ji Mo, Dong-Kwon Rhee, and Suhkneung Pyo: Inhibition of ICAM-1 expression by garlic component, allicin, in gamma-irradiated human vascular endothelial cells via downregulation of the JNK signaling pathway. Int Immunopharmacol 6, 1788-1795 (2006). (Pubitemid 44557187)
136. Min-Hsiung Pan, Yi-Siou Chiou, Wei-Jen Chen, Ju-Ming Wang, Vladimir Badmaev, and Chi-Tang Ho: Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 30, 1234- 1242 (2009).
137. Min-Hsiung Pan, Ying-Ting Lin, Chih-Li Lin, Chi-Shiang Wei, Chi-Tang Ho, and Wei-Jen Chen: Suppression of Heregulin-{beta}1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation. Evid Based Complement Alternat Med (2009).
138. Miaw-Sheue Tsai, Lisa Shamon-Taylor, Inderjit Mehmi, Careen Tang, and Ruth Lupu: Blockage of heregulin expression inhibits tumorigenicity and
139. Feng-Yao Tang, En-Pei Isabel Chiang, and Ya-Chi Sun: Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem 19, 287-294 (2008). (Pubitemid 351503761)
140. Pamela Magee, Hugh McGlynn, and Ian Rowland: Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 208, 35-41 (2004). (Pubitemid 38501781)
141. Sara Javid, Amy Moran, Adelaide Carothers, Mark Redston, and Monica Bertagnolli: Modulation of tumor formation and intestinal cell migration by estrogens in the Apc (Min/+) mouse model of colorectal cancer. Carcinogenesis 26, 587-595 (2005). (Pubitemid 41214148)
142. Rong Pan, Yue Dai, Xing-Hua Gao, Dan Lu, and Yu-Feng Xia: Inhibition of vascular endothelial growth factorinduced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways. Vascul Pharmacol 54, 18- 28 (2011).
143. Georgi Nikov, Nancy Hopkins, Stephen Boue, and William Alworth: Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect 108, 867-872 (2000).
144. Matthew Burow, Stephen Boue, Bridgette Collins-Burow, Lilia Melnik, Bich Duong, Carol Carter-Wientjes, Shuanfang Li, Thomas Wiese, Thomas Cleveland, and John McLachlan: Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J Clin Endocrinol Metab 86, 1750-1758 (2001). (Pubitemid 32377291)
145. Virgilo Salvo, Stephen Boue, Juan Fonseca, Steven Elliott, Cynthia Corbitt, Bridgette Collins-Burow, Tyler Curiel, Sudesh Srivastav, Betty Shih, Carol Carter-Wientjes, Charles Wood, Paul Erhardt, Barbara Beckman, John McLachlan, Thomas Cleveland, and Matthew Burow: Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12, 7159-7164 (2006). (Pubitemid 44974517)
146. Nathaniel Mead: Mining for glyceollins. Environ Health Perspect 115, A189 (2007).
147. Andrew Freedman, Binbing Yu, Mitchell Gail, Joseph Costantino, Barry Graubard, Victor Vogel, Garnet Anderson, and Worta McCaskill-Stevens: Benefit/Risk Assessment for Breast Cancer Chemoprevention with Raloxifene or Tamoxifen for Women Age 50 Years or Older. J Clin Oncol (2011).
148. Charles Wood, Thomas Clarkson, Susan Appt, Adrian Franke, Stephen Boue, Matthew Burow, Thomas McCoy, and Mark Cline: Effects of soybean glyceollins and estradiol in postmenopausal female monkeys. Nutr Cancer 56, 74-81 (2006). (Pubitemid 46173416)
149. Kenneth Setchell: Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20, 354S-362S (2001). (Pubitemid 32948014)
150. Shengbao Feng, Chin Saw, Yuan Lee, and Dejian Huang: Novel process of fermenting black soybean (Glycine max (L.) Merrill) yogurt with dramatically reduced flatulence-causing oligosaccharides but enriched soy phytoalexins. J Agric Food Chem 56, 10078-10084 (2008).
151. Stephen Boue, Syreeta Tilghman, Steven Elliott, Carla Zimmerman, Williams KY, Florastina Payton-Stewart, Allen Miraflor, Melanie Howell, Betty Shih, Carol Carter-Wientjes, Chris Segar, Barbara Beckman, Thomas Wiese, Thomas Cleveland, John McLachlan, and Matthew Burow: Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology 150, 2446- 2453 (2009).
152. Florastina Payton-Stewart, Norberta Schoene, Young Kim, Matthew Burow, Thomas Cleveland, Stephen Boue, and Thomas Wang: Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Mol Carcinog 48, 862-871 (2009).
153. Carla Zimmerman, Syreeta Tilghman, Stephen Boue, Virgilio Salvo, Steven Elliott, K.Y. Williams, Elena Skripnikova, Hasina Ashe, Florastina Payton-Stewart, Lyndsay Vanhoy-Rhodes, Juan Fonseca, Cynthia Corbitt, Bridgette Collins-Burow, Melanie Howell, Michelle Lacey, Betty Shih, Carol Carter-Wientjes, Thomas Cleveland, John McLachlan, Thomas Wiese, Barbara Beckman, and Matthew Burow: Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther 332, 35-45 (2010).
154. Florastina Payton-Stewart, Rahul Khupse, Stephen Boué, Steven Elliott, Carla Zimmermann, Elena Skripnikova, Hasina Ashe, Syreeta Tilghman, Barbara Beckman, Thomas Cleveland, John McLachlan, Deepak Bhatnagar, Thomas Wiese, Paul Erhardt, and Matthew Burow: Glyceollin I enantiomers distinctly regulate ERmediated gene expression. Steroids 75, 870-878 (2010).
155. Mark Cline and Charles Wood: Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis). Am J Primatol 71, 722-731 (2009).
156. Donna Dixon-Shanies and Nina Shaikh: Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep 6, 1383-1387 (1999).
157. Chanfeng Wang and Mindy Kurzer: Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 31, 90- 100 (1998). (Pubitemid 28428068)
158. John Ashby, Helen Tinwell, Anthony Soames, and John Foster: Induction of hyperplasia and increased DNA content in the uterus of immature rats exposed to coumestrol. Environ Health Perspect 107, 819-822 (1999). (Pubitemid 29525135)
159. Liza Valentín-Blasini, Benjamin Blount, Samuel Caudill, and Larry Needham: Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13, 276-282 (2003). (Pubitemid 36999366)
160. Pamela Horn-Ross, Stephen Barnes, Valerie Lee, Christine Collins, Peggy Reynolds, Marion Lee, Susan Stewart, Alison Canchola, Landon Wilson, and Kenneth Jones: Reliability and validity of an assessment of usual phytoestrogen consumption (United States). Cancer Causes Control 17, 85-93 (2006). (Pubitemid 43083674)
161. Stephan Mueller, Margret Kling, Poppy Firzani, Astrid Mecky, Eric Duranti, Jacqueline Shields-Botella, Remi Delansorne, Thomas Broschard, and Peter-Jurgen Kramer: Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogens. Toxicol Lett 142, 89-101 (2003). (Pubitemid 36369218)
162. Farzana Walcott, Michael Hauptmann, Cherie Duphorne, Patricia Pillow, Sara Strom, and Alice Sigurdson: A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer 44, 44-51 (2002). (Pubitemid 36359319)
163. Sara Strom, Yuko Yamamura, Cherie Duphorne, Margaret Spitz, Richard Babaian, Patricia Pillow, and Stephen Hursting: Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33, 20-25 (1999). (Pubitemid 29196118)
164. Richard Hoffman: Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein. Biochem Biophys Res Commun 211, 600-606 (1995).
165. Efrosini Katsanou, Maria Halabalaki, Nektarios Aligiannis, Sofia Mitakou, Alexios-Leandros Skaltsounis, Xanthippi Alexi, Harris Pratsinis, and Michael Alexis: Cytotoxic effects of 2-arylbenzofuran phytoestrogens on human cancer cells: modulation by adrenal and gonadal steroids. J Steroid Biochem Mol Biol 104, 228-236 (2007). (Pubitemid 46901031)
166. Barry Gehm, Joanne McAndrews, Pei-Yu Chien, and Larry Jameson: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94, 14138- 14143 (1997). (Pubitemid 28009723)
167. Jennifer Bowers, Valentyn Tyulmenko, Sarah Jernigan, and Carolyn Klinge: Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141, 3657-3667 (2000).
168. Takako Sakamoto, Hyogo Horiguchi, Etsuko Oguma, and Fujio Kayama: Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem 21, 856-864 (2010).
169. Fang Lu, Muhammad Zahid, Cheng Wang, Muhammad Saeed, and Ercole Cavalieri, and Eleanor Rogan: Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res 1, 135-145 (2008).
170. Andreas Papoutsis, Sarah Lamore, Georg Wondrak, Ornella Selmin, and Donato Romagnolo: Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr 140, 1607-1614 (2010).
171. Naoki Harada, Kiyotaka Atarashi, Yohei Murata, Ryoichi Yamaji, Yoshihisa Nakano, and Hiroshi Inui: Inhibitory mechanisms of the transcriptional activity of androgen receptor by resveratrol: Implication of DNA binding and acetylation of the receptor. J Steroid Biochem Mol Biol 123, 65-70 (2011).
172. Stephanie Degner, Andreas Papoutsis, Ornella Selmin, and Donato Romagnolo: Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3, 3'- diindolylmethane in breast cancer cells. J Nutr 139, 26-32 (2009).
173. Thomas Wang, Tamaro Hudson, Tien-Chung Wang, Connie Remsberg, Neal Davies, Yoko Takahashi, Young Kim, Harold Seifried, Bryan Vinyard, Susan Perkins, and Stephen Hursting: Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29, 2001-2010 (2008).
174. Ken Itoh, Tomoki Chiba, Satoru Takahashi, Tetsuro Ishii, Kazuhiko Igarashi, Yasutake Katoh, Tatusya Oyake, Norto Hayashi, Kimihiko Satoh, Ichiro Hatayama, Masayuki Yamamoto, and Yo-ichi Nabeshima: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313-322 (1997). (Pubitemid 27373291)
175. Woo-Sik Jeong, Mira Jun, and Ah-Ng Kong: Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 8, 99-106 (2006). (Pubitemid 43324535)
176. John Hayes, Michael Kelleher, and Ian Eggleston: The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 47, 73-88 (2008). (Pubitemid 351644183)
177. Anil Jaiswal: Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36, 1199- 207 (2004). (Pubitemid 38526313)
178. Sung-Jin Lee, Kung-Woo Nam, and Woongchon Mar: Induction of quinone reductase activity by psoralidin isolated from Psoralea corylifolia in mouse hepa 1c1c7 cells. Arch Pharm Res 32, 1061-1065 (2009).
179. Nira Izigov, Nahid Farzam, and Naphtali Savion: Sallylmercapto- N-acetylcysteine up-regulates cellular glutathione and protects vascular endothelial cells from oxidative stress. Free Radic Biol Med 50, 1131-1139 (2011).
180. Limor Horev-Azaria, Shlomit Eliav, Nira Izigov, Sarah Pri-Chen, David Mirelman, Talia Miron, Aharon Rabinkov, Meir Wilchek, Jasmine Jacob-Hirsch, Ninette Amariglio, and Naphtali Savion: Allicin up-regulates cellular glutathione level in vascular endothelial cells. Eur J Nutr 67-74 (2009).
181. Varsha Singh, Daurat Belloir, Marie-Helen Siess MH, and Anne Le Bon: Inhibition of carcinogen-induced DNA damage in rat liver and colon by garlic powders with varying alliin content. Nutr Cancer 55, 178-184 (2006). (Pubitemid 44719632)
182. Christine Belloir, Varsha Singh, Caroline Daurat, Marie-Helen Siess, and Anne Le Bon: Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells. Food Chem Toxicol 44, 827-834 (2006).
183. Bertrand Piver, Francois Berthou, Yvonne Dreano, and Daniele Lucas: Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 125, 83-91 (2001). (Pubitemid 33043758)
184. Dominique Delmas, Allan Lancon, Didier Colin, Brigitte Jannin, and Norbert Latruffe: Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 7, 423-442 (2006). (Pubitemid 43744833)
185. Sherry Chow, Linda Garland, Chiu-Hsieh Hsu, Donna Vining, Wade Chew, Jessica Miller, Marjorie Perloff, James Crowell, and David Alberts: Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res 3, 1168-1175 (2010).
186. Henry Ciolino, Phillip Daschner, and GraceYeh: Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58, 5707-5712 (1998). (Pubitemid 29006410)
187. Maura Floreani, Eleonora Napoli, Luigi Quintieri, and Pietro Palatini: Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci 72, 2741-2750 (2003). (Pubitemid 36385079)
188. Hanna Szaefer, Michal Cichocki, Damian Brauze, and Wanda Baer-Dubowska: Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons- DNA adduct formation by plant phenolics in mouse epidermis. Nutr Cancer 48, 70-77 (2004). (Pubitemid 38823548)
189. Donatella Canistro, Barbara Bonamassa, Laura Pozzetti, Andrea Sapone, Sherif Abdel-Rahman, Gian Biagi, and Moreno Paolini: Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food Chem Toxicol 47, 454-461 (2009).
190. Juan Rubiolo, Gilles Mithieux, and Felix Vega: Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591, 66-72 (2008).
191. Anupam Bishayee, Kendra Barnes, Deepak Bhatia, Altaf Darvesh, and Richard Carroll: Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev Res 3, 753-763 (2010).
192. Michael Haack, Maria Löwinger, Doris Lippmann, Anna Kipp, Eleonora Pagnotta, Renato Iori, Berhard Monien, Hansruedi Glatt, Martin Brauer, Ludger Wessjohann, and Regina Brigelius-Flohé: Breakdown products of neoglucobrassicin inhibit activation of Nrf2 target genes mediated by myrosinase-derived glucoraphanin hydrolysis products. Biol Chem 391, 1281- 1293 (2010).
193. Paolo Perocco, Giorgio Bronzetti, Donatella Canistro, Luca Valgimigli, Andrea Sapone, Alessandra Affatato, Gian Pedulli, Laura Pozzetti, Massimiliano Broccoli, Renato Iori, Jessica Barillari, Valeriana Sblendorio, Marvin Legator, Moreno Paolini, and Sherif Abdel-Rahman: Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces phase-I xenobiotic metabolizing enzymes and increases free radical generation in rat liver. Mutat Res 595, 125-136 (2006). (Pubitemid 43277856)
194. Ahmad Abdull Razis, Manuele Bagatta, Gina De Nicola, Renato Iori, and Costas Ioannides: Intact glucosinolates modulate hepatic cytochrome P450 and phase II conjugation activities and may contribute directly to the chemopreventive activity of cruciferous vegetables. Toxicology 277, 74-85 (2010).
195. Elisabeth Wenzel, Tomislav Soldo, Helmut Erbersdobler, and Veronika Somoza: Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 249, 482-494 (2005). (Pubitemid 40780395)
196. Shunso Hatono, Arnie Jimenez, and Michael Wargovich: Chemopreventive effect of Sallylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 17, 1041-1044 (1996). (Pubitemid 26158402)
197. David Boocock, Guy Faust, Ketan Patel, Anna Schinas, Victoria Brown, Murray Ducharme, Tristan Booth, James Crowell, Marjorie Perloff, Andreas Gescher, William Steward, and Dean Brenner: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16, 1246-1252 (2007). (Pubitemid 46984966)
198. Ketan Patel, Victoria Brown, Donald Jones, Robert Britton, David Hemingway, Andrew Miller, Kevin West, Tristan Booth, Marjorie Perloff, James Crowell, Dean Brenner, William Steward, Andreas Gescher, and Karen Brown: Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70, 7392-7399 (2010).
199. Victoria Brown, Ketan Patel, Maria Viskaduraki, James Crowell, Marjorie Perloff, Tristan Booth, Grygoriy Vasilinin, Ananda Sen, Anna Schinas, Gianfranca Piccirilli, Karen Brown, William Steward, Andreas Gescher, and Dean Brenner: Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70, 9003-11 (2010).